PASG

Passage BIO, Inc.

Healthcare · Biotechnology

$44.42 sample

-0.66 (-1.46%) 1D

Market cap

$228.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-22

Alerts

8

Price$44.42 -5.04% 3M daily closessample

46.8042.42

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: 10% owner
Oct 05INSInsider sell: General Counsel
Sep 29INSInsider sell: Chief Executive Officer
Sep 22SEC10-Q filed
Sep 14SECDEF 14A filed
Sep 03INSInsider sell: Chief Executive Officer
Aug 31INSInsider sell: General Counsel
Aug 20INSInsider sell: EVP, Operations

Sign up to see the real PASG record →

Company facts

SEC EDGAR registration

Name: Passage BIO, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -30sample, -100 to +100
Reporting currency: USD

Who is positioning in PASG

sample

Insiders: 14 insider transactions over 90 days, net selling, $322.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 39 funds hold $4.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.8B +19.4% y/y

Q4 2024Q3 2026

Inventory$4.6B +14.9% y/y

Q4 2024Q3 2026

Accounts receivable$3.6B +12.0% y/y

Q4 2024Q3 2026

Total debt$8.8B +3.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $214.9B +1.1% 3M
Sample peer B: $91.0B -1.0% 3M
Sample peer C: $218.5B -4.4% 3M
Sample peer D: $69.7B +16.1% 3M
Sample peer E: $109.5B +2.5% 3M